The 14-year incidence of lower-extremity amputations in a diabetic population: The Wisconsin Epidemiologic Study of Diabetic Retinopathy

Diabetes Care

Volumn 22, Issue 6, 1999, Pages 951-959

  Moss, Scot E ^a,b   Klein, Ronald ^a   Klein, Barbara E K ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DRUG USE; FEMALE; FOOT ULCER; HUMAN; INCIDENCE; INTERVIEW; LEG AMPUTATION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PULSE PRESSURE; RISK FACTOR; SMOKING;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; AGED; AMPUTATION; ASPIRIN; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; DIABETIC RETINOPATHY; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RISK FACTORS; WISCONSIN;

EID: 0032968988     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.6.951     Document Type: Article

References (58)

1. Most RS, Sinnock P: The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 6:87-91, 1983
2. Siitonen OI, Niskanen LK, Laakso M, Siitonen JT, Pyorala K: Lower-extremity amputations in diabetic and nondiabetic patients: a population-based study in eastern Finland. Diabetes Care 16:16-20, 1993
3. van Houtum WH, Lavery LA, Harkless LB: The impact of diabetes-related lower-extremity amputations in the Netherlands. J Diabetes Complications 10:325-330, 1996
4. Trautner C, Haastert B, Giani G, Berger M: Incidence of lower limb amputations and diabetes. Diabetes Care 19:1006-1009, 1996
5. Armstrong DG, Lavery LA, van Houtum WH, Harkless LB: The impact of gender on amputation. J Foot Ankle Surg 36:66-69, 1997
6. Morris AD, McAlpine R, Steinke D, Boyle DIR, Ebrahim A-R, Vasudev N, Stewart CPU, Jung RT, Leese GP, MacDonald TM, Newton RW for the DARTS/MEMO Collaboration. Diabetes and lower-limb amputations in the community: a retrospective cohort study. Diabetes Care 21:738-743, 1998
7. Humphrey LL, Palumbo PJ, Butters MA, Hallett JW; Chu C-P, O'Fallon WM, Ballard DJ: The contribution of non-insulin-dependent diabetes to lower-extremity amputation in the community. Arch Intern Med 154:885-892, 1994
8. van Houtum WH, Lavery LA: Outcomes associated with diabetes-related amputations in the Netherlands and in the state of California, USA. J Int Med 240:227-231, 1996
9. Griffiths GD, Wieman TJ: Meticulous attention to foot care improves the prognosis in diabetic ulceration of the foot. Surg Gynecol Obstet 174:49-51, 1992
10. Malone JM, Snyder M, Anderson G, Bernhard VM, Holloway GA Jr, Bunt TJ: Prevention of amputation by diabetic education. Am J Surg 158:520-524, 1989
11. Litzelman DK, Slemenda CW, Langefeld CD, Hays LM, Welch MA, Bild DE, Ford ES, Vinicor F: Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus: a randomized, controlled trial. Ann Intern Med 119:36-41, 1993
12. Rith-Najarian S, Branchaud C, Beaulieu O, Gohdes D, Simonson G, Mazze R: Reducing lower-extremity amputations due to diabetes: application of the staged diabetes management approach in a primary care setting. J Fam Pract 47:127-132, 1998
13. Moss SE, Klein R, Klein BEK: The prevalence and incidence of lower extremity amputation in a diabetic population. Arch Intern Med 152:610-616, 1992
14. Moss SE, Klein R, Klein BEK: Long-term incidence of lower-extremity amputations in a diabetic population. Arch Fam Med 5:391-398, 1996
15. Klein R, Klein BEK, Moss SE, DeMets DL, Kaufman I, Voss PS: Prevalence of diabetes mellitus in southern Wisconsin. Am J Epidemiol 119:54-61, 1984
16. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy, II: prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520-526, 1984
17. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy, III: prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102:527-532, 1984
18. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy, IX: four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 107:237-243, 1989
19. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy, X: four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol 107:244-249, 1989
20. Klein R, Klein BEK, Moss SE, Cruickshanks KJ: The Wisconsin Epidemiologic Study of Diabetic Retinopathy XIV: ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 112:1217 1228, 1994
21. Klein R, Klein BEK, Moss SE, Cruickshanks KJ: The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type I diabetes. Ophthalmology 105: 1801-1815, 1998
22. Moss SE, Klein R, Klein BEK, Spennetta TL, Shrago ES: Methodologie considerations in measuring glycosylated hemoglobin in epidemiologic studies. J Clin Epidemiol 41:645-649, 1988
23. Faber OK, Binder C, Markussen J, Heding LG, Naithani VK, Kuzuya H, Blix P, Horwitz DL, Rubenstein AH: Characterization of seven C-peptide antisera. Diabetes 27 (Suppl. 1):170-177, 1978
24. Wiebe DA, Bernert JT Jr: Influence of incomplete cholesteryl ester hydrolysis on enzymic measurements of cholesterol. Clin Chem 30:352-356, 1984
25. Abell LL, Levy BB, Brodie BB, Kendall FE: A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem 195:357-366, 1952
26. Lopes-Virella MF, Stone P, Ellis S, Colwell JA: Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 23:882-884, 1977
27. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
28. Mantel N : Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 58:690-700, 1963
29. Hosmer DW Jr, Lemeshow S: Applied Logistic Regression. New York, Wiley & Sons, 1989, p. 238-245
30. Miller AD, Van Buskirk A, Verhoek-Oftedahl W, Miller ER: Diabetes-related lower extremity amputations in New Jersey, 1979 to 1981. J Med Soc N J 82:723-726, 1985
31. Nelson RG, Gohdes DM, Everhart JE, Hartner JA, Zwemer FL, Pettitt DJ, Knowler WC: Lower-extremity amputations in NIDDM: 12-yr follow-up study in Pima Indians. Diabetes Care 11:8-16, 1988
32. DeStefano F. Dougherty BL, Ford ES, German RR, Newman JM, Olson DR, Sepe SJ, Stevenson JM, Vinicor F. Wetterhall SF Will JC: Diabetes Surveillance, 1980-1987. Atlanta, GA, Centers for Disease Control, 1990, p. 23-25
33. Deerochanawong C, Home PD, Alberti KGMM: A survey of lower limb amputation in diabetic patients. Diabet Med 9:942-946, 1992
34. Rith-Najarian SJ, Valway SE, Gohdes DM: Diabetes in a northern Minnesota Chippewa tribe: prevalence and incidence of diabetes and incidence of major complications, 1986-1988. Diabetes Care 16:266-270, 1993
35. Lee JS, Lu M, Lee VS, Russell D, Bahr C, Lee ET: Lower-extremity amputation: incidence, risk factors, and mortality in the Oklahoma Indian Diabetes Study Diabetes 42:876-882, 1993
36. Lavery LA, Ashry HR, van Houtum W, Pugh JA, Harkless LB, Basu S: Variation in the incidence and proportion of diabetes-related amputations in minorities. Diabetes Care 19:48-52, 1996
37. Lehto S, Ronnemaa T, Pyorala K, Laakso M: Risk factors predicting lower extremity amputations in patients with NIDDM. Diabetes Care 19:607-612, 1996
38. Humphrey ARG, Dowse GK, Thoma K, Zimmet PZ: Diabetes and nontraumatic lower extremity amputations: incidence, risk factors, and prevention: a 12-year follow-up study in Nauru. Diabetes Care 19:710-714, 1996
39. Reiber GE, Pecoraro RE, Koepsell TD: Risk factors for amputation in patients with diabetes mellitus: a case-control study. Ann Intern Med 117:97-105, 1992
40. Selby JV, Zhang D: Risk factors for lower extremity amputations in persons with diabetes. Diabetes Care 18:509-516, 1995
41. Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke 27:2033-2039, 1996
42. Gray RP, Yudkin JS: Cardiovascular disease in diabetes mellitus. In Pickup JC, Williams G, Eds. Textbook of Diabetes, Vol. 2. Oxford, Blackwell Science, 1997, p. 1-22
43. Colwell JA: Aspirin therapy in diabetes. Diabetes Care 20:1767-1771, 1997
44. American Diabetes Association: Aspirin therapy in diabetes. Diabetes Care 20:1772-1773, 1997
45. Chew EY, Klein ML, Murphy RP, Remaley NA, Ferris FL III for the Early Treatment Diabetic Retinopathy Study Research Group: Effects of aspirin on vitreous/preretinal hemorrhage in patients with diabetes mellitus: Early Treatment Diabetic Retinopathy Study Report no. 20. Arch Ophthalmol 113:52-55, 1995
46. Flores Rivera AR: Risk factors for amputation in diabetic patients: a case-control study. Arch Med Res 29:179-184, 1998
47. Bell DSH: Alcohol and the NIDDM patient. Diabetes Care 19:509-513, 1996
48. McCulloch DK, Campbell IW, Prescott RJ, Clarke BF: Effect of alcohol intake on symptomatic peripheral neuropathy in diabetic men. Diabetes Care 3:245-247, 1980
49. Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, Nuber A, Pozza G, Ward JD, EURODIAB IDDM Study Group: Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study Diabetologia 39:1377-1384, 1996
50. Adler AI, Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Smith DG: Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study Diabetes Care 20:1162-1167, 1997
51. Cameron HC, Lennard-Jones JE, Robinson MP: Amputations in the diabetic: outcome and survival. Lancet 2:605-607, 1964
52. Whitehouse FW, Jurgensen C, Block MA: The later life of the diabetic amputee: another look at the fate of the second leg. Diabetes 17:520-521, 1968
53. Lindegard P, Jonsson B, Lithner F: Amputations in diabetic patients in Gotland and Umea counties, 1971-1980. Acta Med Scand 687 (Suppl.):89-93, 1984
54. Klein R, Moss SE, Klein BEK, DeMets DL: Relation of ocular and systemic factors to survival in diabetes Arch Intern Med 149:266-272, 1989
55. Turner R, Holman R, Stratton I, Cull C, Frighi V, Manley S, Matthews D, Neil A, McElroy H, Kohner E, Fox C, Hadden D, Wright D, UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317:703-713, 1998
56. Reichard P, Nilsson B-Y, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993
57. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993
58. UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and nsk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998